26
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9723 |
GluR6 antagonist-1
|
Src | Angiogenesis; Tyrosine Kinase/Adaptors |
GluR6 antagonist-1 抑制酪氨酸激酶 p56lck SH2 结构域的 pY 结合位点。 | |||
T82295 |
GluR23Y
|
||
GluR23Y是一种具有生物活性的肽,应用于ELISA细胞表面测定,专用于监测培养的海马神经元内AMPA受体在胰岛素刺激下的内吞情况。该肽能够阻止由胰岛素引起的AMPA受体数量的下降。通过将GluR23Y与HIV-1的膜转导结构域融合,实现对神经元的传递,从而有效抑制了胰岛素诱导的效应。 | |||
T80246 |
TAT-GluR23A Fusion Peptide
|
||
TAT-GluR23A Fusion Peptide 是一种肽,具有特定的生物活性。该化合物由 GluR23A 序列结合至 TAT 蛋白转导结构域(PTD),其中 GluR23A 为 GluR23Y(一种无生物活性肽,用于抑制谷氨酸受体的内吞)的突变体,其由氨基酸 869 至 877 构成,并将 Tyr 用 Ala 代替,移除了关键的磷酸化位点。 | |||
T15090 |
Decoglurant
RO4995819 |
GluR | Neuroscience |
Decoglurant (RO4995819) 是 mGluR2和 mGluR3的负变构调制器,有抗抑郁作用。 | |||
T12717 |
Basimglurant
CTEP Derivative,RG7090 |
GluR | Neuroscience |
Basimglurant (CTEP Derivative) 是一种高效,选择性,可口服的 mGlu5负变构调节剂,Kd 值为1.1 nM。 | |||
T35028 |
Valiglurax
VU2957,VU 0652957,VU 2957,VU-0652957,VU0652957,VU-2957 |
GluR | Neuroscience |
Valiglurax (VU2957),也称为 VU0652957和 VU2957,是一种强效、选择性、中枢神经系统渗透剂,可口服生物利用的 mGlu4正变构调节剂。VU2957具有良好的跨物种的体内外药理学和药代动力学性质。VU2957被评估为治疗帕金森病的临床前开发候选药物。 | |||
T9970 |
mGluR3 modulator-1
1-ethyl-3-(morpholin-4-yl)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile,1-乙基-3-(1,4-氧杂氮杂环己-4-基)-5,6,7,8-四氢异喹啉-4-甲腈 |
GluR | Neuroscience |
mGluR3 modulator-1 (1-ethyl-3-(morpholin-4-yl)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile) 是 mGluR3 的正变构调节剂,可用于治疗帕金森病的研究。 | |||
T38612 |
Linaprazan glurate
|
Others | Others |
Linaprazan glurate 抑制外源性或内源性刺激的胃酸分泌。 Linaprazan glurate 可用于胃肠道炎症性疾病和消化性溃疡疾病的研究。 | |||
T11951 |
Mavoglurant racemate
AFQ-056 racemate |
Others | Others |
Mavoglurant is a novel, non-competitive mGlu5 receptor antagonist. Mavoglurant (racemate) is the racemate of mavoglurant. | |||
T11311 |
Foliglurax monohydrochloride
PXT002331 (monohydrochloride) |
Others | Others |
Foliglurax monohydrochloride Antiparkinsonian effect. is a highly selective and potent, brain-penetrant metabotropic glutamate receptor 4 positive allosteric modulator (mGluR4 PAM) , with an EC50 of 79 nM. | |||
T11311L |
Foliglurax
PXT002331 |
GluR | Neuroscience |
Foliglurax is a highly selective brain-penetrant metabotropic glutamate receptor 4 positive allosteric modulator (mGluR4 PAM) (EC50: 79 nM). | |||
T61277 | mGluR2 modulator 4 | ||
mGluR2 modulator 4 (compound 47) is a highly potent positive allosteric modulator of mGluR2, exhibiting an EC 50 value of 0.8 μM. It holds the potential for investigating antipsychotic properties [1]. | |||
T81801 |
mGluR5 antagonist-1
|
||
mGluR5 antagonist-1,一种高亲和力的mGluR5拮抗剂,其IC50为11.5 nM,表现出抗抑郁活性。 | |||
T32080 |
Histidine oxoglurate
Histidine alpha-ketoglutarate |
||
Histidine oxoglurate is a bioactive chemical. | |||
T17241 |
Auglurant
VU0424238 |
Others | Others |
Auglurant is a novel and selective mGlu5 antagonist (IC50: 11 nM (rat) and an IC50: 14 nM (human)). Auglurant has an acceptable CNS penetration. | |||
T38910 |
mGluR2 antagonist 1
|
||
mGluR2 antagonist 1 is a potent and selective class of negative allosteric modulator targeting the metabotropic glutamate receptor 2 (mGluR2) with high oral bioavailability. It displays a remarkable affinity for mGluR2, with an IC50 value of 9 nM. Furthermore, it exhibits excellent permeability across the blood-brain barrier, making it a promising candidate for central nervous system-related studies or therapies. | |||
T60882 | mGluR2 modulator 2 | ||
mGluR2 modulator 2 (compound 2) 可用于抗精神病药物研究。mGluR2 modulator 2 是一种有效的、选择性和口服生物可利用的mGluR2正变构调节剂,EC50值为 0.13 μM。 | |||
T15134 |
Dipraglurant
ADX48621 |
Others | Others |
Dipraglurant 是一种可透过血脑屏障的 mGluR5 的负变构调节剂 (NAM),具有有效性,选择性和口服活性,其 IC50 值为 21 nM。Dipraglurant 可治疗帕金森病左旋多巴诱导的运动障碍(PD-LID)。 | |||
T62202 |
mGluR2 modulator 1
|
||
mGluR2 modulator 1 (compound 95) 是一种有效的、具有血脑屏障通透性的 mGluR2 (代谢型谷氨酸受体-2)正向变构调节剂 (EC50: 0.03 μM)。mGluR2 modulator 1 能够用于研究精神病。 | |||
T34282 |
Remeglurant
|
||
Remeglurant is used as a selective antagonist of the mGlu5 receptor. | |||
T38659 |
mGluR5 modulator 1
|
||
mGluR5 modulator 1 is a compound that acts as a positive allosteric modulator of the metabotropic glutamate receptor subtype 5 (mGluR5). Its primary application lies in the field of schizophrenia and cognitive impairment research. | |||
T6562 |
Latrepirdine dihydrochloride
Dimebolin dihydrochloride,Latrepirdine,Latrepirdine 2HCl,Dimebolin |
Beta Amyloid; 5-HT Receptor; Adrenergic Receptor; GluR; Autophagy; Histamine Receptor | Autophagy; GPCR/G Protein; Immunology/Inflammation; Neuroscience |
Latrepirdine dihydrochloride (Dimebolin dihydrochloride) 是一种具有口服活性和神经活性的多种药物靶点的拮抗剂,可刺激淀粉样前体蛋白分解代谢和 β-淀粉样蛋白分泌。 | |||
T3486 |
3-MATIDA
|
GluR; NMDAR | Neuroscience |
3-MATIDA 是一种有效的 mGluR-1 拮抗剂(IC50:6.3 μM,大鼠 mGluR-1a)。显示出 ≥ 40 倍于其他受体的选择性:mGluR-5、mGluR-2、mGluR-4 (mGluR-4a) (IC50 > 300 μM)、NMDA 和 GluR (AMPA) (IC50 = 250 μM)。 3-MATIDA 在体外培养的鼠皮质细胞和大鼠海马切片培养物中充当神经保护剂。 | |||
T14130 |
Adomeglivant
LY2409021 |
Glucagon Receptor | GPCR/G Protein |
Adomeglivant (LY2409021) 是一种高效的选择性胰高血糖素受体 (GluR) 变构拮抗剂,主要用于2型糖尿病的研究。 | |||
T81912 | LSP-GR3 | iGluR | Membrane transporter/Ion channel; Neuroscience |
LSP-GR3为一种新型化学修饰RNA寡核苷酸,亦即剪接调控寡聚体(SMOs),可特异性调控中枢神经系统内GluR的选择性剪接及GluR3-flip表达。 | |||
T76278 | Efinopegdutide | ||
Efinopegdutide (JNJ-64565111) 是一种高效的胰高血糖素样肽-1 (GLP-1) /胰高血糖素受体 (GluR) 双重激动剂,具有同时激活GLP-1和胰高血糖素受体的能力,主要用于非酒精性脂肪性肝炎 (NASH) 的研究领域。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8626 |
Transtorine
1,4-DIHYDRO-4-OXOQUINOLINE-2-CARBOXYLIC ACID,1,4-二氢-4-氧代喹啉-2-羧酸 |
GluR; NMDAR | Neuroscience |
Transtorine (1,4-DIHYDRO-4-OXOQUINOLINE-2-CARBOXYLIC ACID) 是一种 GluR 和 NMDA 抑制剂。 | |||
T20191 |
(-)-Camphoric acid
(-)-樟脑酸,L-Camphoric acid,Camphoric acid, (-)- |
GluR | Neuroscience |
(-)-Camphoric acid (L-Camphoric acid) 是一种活性较低的樟脑酸对映异构体,樟脑酸可诱导 GluR 表达。 |